Literature DB >> 195193

Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors.

T Asano, Y Ochiai, H Hidaka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 195193

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  6 in total

1.  Adenosine and adenosine analogs inhibit phosphodiesterase activity in the heart.

Authors:  W Meyer; M Nose; W Schmitz; H Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

2.  The time course of changes in cyclic nucleotide levels during cholinergic inhibition of positive inotropic actions of isoprenaline and theophylline in the isolated canine ventricular myocardium.

Authors:  M Endoh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

3.  Effects of phthalazinol on smooth muscle cells of the porcine coronary artery and on neuromuscular junction on the guinea-pig vas deferens.

Authors:  K Kitamura; K Tajima; M Kamata; Y Ito; H Kuriyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-03       Impact factor: 3.000

4.  Dipyridamole increases human red blood cell deformability.

Authors:  A R Saniabadi; T C Fisher; C S Lau; A Bridges; J Taylor; J Belch; C D Forbes
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Additive effects of statin and dipyridamole on cerebral blood flow and stroke protection.

Authors:  Hyung-Hwan Kim; Naoki Sawada; Guray Soydan; Ho-Seong Lee; Zhipeng Zhou; Seo-Kyoung Hwang; Christian Waeber; Michael A Moskowitz; James K Liao
Journal:  J Cereb Blood Flow Metab       Date:  2008-04-02       Impact factor: 6.200

6.  Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.

Authors:  U Schwabe; D Ukena; M J Lohse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.